News

Article

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2003
Volume27
Issue 7

Capacity Worries Fade for Biomanufacturing

Author(s):

Jim Miller

The DSM investment puts biomanufacturing capacity in the spotlight. Contract biomanufacturers are adding new capacity and sponsors are marketing their excess capacity.

External Link - article-62505.pdf

Articles in this issue
July 2003
Gastrorentention: A Means to Address Regional Variability in Intestinal Drug Absorption
The Push for Generics Challenges Manufacturers
Emerging Research Opportunities in Oral Inhalation Technology
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
Preventing Metal Contamination
Capacity Worries Fade for Biomanufacturing

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content
Glass vials for liquid samples. | Image Credit: ©nordroden - stock.adobe.com
July 31st 2025

Flexibility Provides Solutions to Small-Batch Manufacturing Challenges

Susan Haigney
Modular process design, single-use technologies, and flexible filling lines are some of the ways manufacturers can combat challenges involved in small-batch manufacturing.
Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends
July 31st 2025

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.
Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com
July 31st 2025

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

Patrick Lavery
The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.
Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically
July 31st 2025

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
July 31st 2025

Aenova Adds Cold Chain Warehouse to Latina, Italy Site

Susan Haigney
The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.
Close up the media plate on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory. | Image Credit: © analysis121980 - stock.adobe.com
July 31st 2025

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

Patrick Lavery
Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.